IMNM WACC - Weighted Average Cost of Capital
The WACC of Immunome Inc (IMNM) is 5.8%.
| Range | Selected | |
| Cost of equity | 7.0% - 8.9% | 7.95% |
| Tax rate | 26.2% - 27.0% | 26.6% |
| Cost of debt | 5.0% - 5.0% | 5% |
| WACC | 5.3% - 6.3% | 5.8% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.67 | 0.72 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.0% | 8.9% |
| Tax rate | 26.2% | 27.0% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.0% | 5.0% |
| After-tax WACC | 5.3% | 6.3% |
| Selected WACC | 5.8% | |
| Debt/Equity | Unlevered | |||
| Peers | Company Name | ratio | Beta | beta |
| IMNM | Immunome Inc | 1.01 | 2.08 | 1.2 |
| 950220.KQ | Neoimmunetech Inc (Pre-reincorporation) | 0.01 | 0.08 | 0.08 |
| ABBV | Abbvie Inc | 0.21 | 0.34 | 0.29 |
| AMGN | Amgen Inc | 0.4 | 0.4 | 0.31 |
| DBTX | Decibel Therapeutics Inc | 0 | 1.71 | 1.71 |
| GILD | Gilead Sciences Inc | 0.19 | 0.34 | 0.3 |
| GRTX | Galera Therapeutics Inc | 71.37 | 0.66 | 0.01 |
| IBIO | Ibio Inc | 1.12 | 0.78 | 0.43 |
| KZR | Kezar Life Sciences Inc | 0.32 | 0.95 | 0.77 |
| ONCR | Oncorus Inc | 6.17 | 2.04 | 0.37 |
| TRVN | Trevena Inc | 31.3 | 0.8 | 0.03 |
| Low | High | |
| Unlevered beta | 0.3 | 0.37 |
| Relevered beta | 0.51 | 0.58 |
| Adjusted relevered beta | 0.67 | 0.72 |
IMNM's CAPM model and how its cost of Equity is calculated
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for IMNM:
cost_of_equity (7.95%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.67) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.